TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: maximum physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue and limitations in daily activities
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: anti-Aβ antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Self-reported physical mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vaginal maturation index (VMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: nursing home use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Relief of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Trunk stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Absolute Error (MAE) of Joint Position Sense (JPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COAT total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Child hyperactivity/inattention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest tube insertion rates
Endpoint domain: Adverse events/effects
Primary endpoint: Parent-assessed severe sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum free IgE concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wheal-and-flare reactions to skin tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Use of emergency contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Human papillomavirus clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intensity of sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attempts for venous access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter lifespan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean primary operator radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symmetric sensory block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphologic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity to detect epileptiform discharges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specificity to detect epileptiform discharges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean score of MCPIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-emergent cardiovascular adverse events (CV AEs) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: PISQ-12 score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: UDI-6 score
Endpoint domain: Life impact
Endpoint subdomain: Urinary functioning
Primary endpoint: IIQ-7 score
Endpoint domain: Life impact
Endpoint subdomain: Urinary functioning
Primary endpoint: Specificity of bright-light measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of bright-light measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LV inflow deceleration time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: complete mucosal healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of hypoglycemic episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Ameliorating symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improving quality of life (QOF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Thyroid gland volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSH suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change of direction (COD) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Digit span performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of IBTR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: breast cancer specific survival
Endpoint domain: Mortality/survival
Primary endpoint: Adiponectin plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Skin microvascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of use of EBM resources
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of writing down clinical questions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vocabulary score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pressure ulcer development
Endpoint domain: Adverse events/effects
Primary endpoint: Self-care knowledge improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disappearance of SIBO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in general gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pelvic floor muscle endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Resonant frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correct demonstration of epinephrine administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Key step errors in administration
Endpoint domain: Adverse events/effects
Primary endpoint: PDAI (Pouch Disease Activity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of drug-related adverse events (DAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: quantity of alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: behavioural knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of acute oral mucositis (OM) grade ≥ 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time before occurrence of OM ≥ grade 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of LLLT/PBMT
Endpoint domain: Adverse events/effects
Primary endpoint: Change in high-sensitive C-reactive protein (hs-CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hospital admission with return of spontaneous circulation
Endpoint domain: Mortality/survival
Primary endpoint: survival with favorable neurological outcome
Endpoint domain: Mortality/survival
Primary endpoint: Cure rate of T. trichiura infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Egg-reduction rate for T. trichiura infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Antihypertensive medications adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-acting beta agonist adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of current smokers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hypertension/preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: prevalence of respiratory infections
Endpoint domain: Adverse events/effects
Primary endpoint: exogenous infectious events
Endpoint domain: Adverse events/effects
Primary endpoint: f/VT ratio as a predictor of successful weaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement in scores of the Controlled Oral Word Association Test (COWAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean IC over 4 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bone Mineral Apparent Density (BMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median costs for pancreatic surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total effective rate of neurophysiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: good rate of basic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: curemarkedly effective rate of practical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in AUC for delayed-release acetaminophen preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 6-month survival with good neurologic outcome
Endpoint domain: Mortality/survival
Primary endpoint: Impact on clinical actions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of a new or different treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: telomere length changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiorespiratory fitness (VO2peak) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of keratometry measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amygdala response to neutral faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: amygdala activation for sad vs neutral faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients achieving response at end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: secretion rate of s‐IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of URTI
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative atrial fibrillation (AF) development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events (hypotension, bradycardia, left ventricular failure)
Endpoint domain: Adverse events/effects
Primary endpoint: Partial remission of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute PONV (0-6 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-discharge PONV (6-24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time taken for fissure healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients redeeming prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of dispensed drugs for cardiovascular diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proliferation inhibition ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell migration number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure-related exit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Recovery of intestinal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequencies of postoperative abdominal distension
Endpoint domain: Adverse events/effects
Primary endpoint: Frequencies of pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Rotator Cuff-Quality of Life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sensory deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Eccentric and concentric torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tegner Hop Test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm Knee Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TB infection
Endpoint domain: Adverse events/effects
Primary endpoint: Negative appendicectomy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Insulin sensitivity and secretion indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucagon release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of fall-induced injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated peak oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of chronic asymptomatic bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Accuracy of GHRH+Arg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability of GHRH+Arg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subject acceptability of GHRH+Arg test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maximal voluntary isometric torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: fatigue resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Acute febrile respiratory illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ear ailments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye ailments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom disappearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse reactions related to drugs
Endpoint domain: Adverse events/effects
Primary endpoint: maximum load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: work to 10-mm displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of anaphylaxis
Endpoint domain: Adverse events/effects
Primary endpoint: Severity scores during ragweed season
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between SAFT and oral challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nirschl score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative severity and size of misregistration and artifactual defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 15 year freedom from progression (FFP)
Endpoint domain: Mortality/survival
Primary endpoint: Correct drug administration during ventricular fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct dosage selection of lidocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriate ordering of MgSO4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Susceptibility of HDL(2&3) to oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activities of HDL(2&3)-PON-1 and HDL(2)-LCAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with partial or complete sensory block of the femoral nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of needle redirections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer depth reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glutathione depletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nausea/vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Anaesthetic-analgesic quality rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean creatinine at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Freedom from acute rejection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: sputum IL‐8 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients reaching relative functional independence on the Barthel Index at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of women with IUAs at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: FGL (Graft Length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean plaque volume in the aortic artery wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glucose tolerance impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incremental area under the curve (AUC) of plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum concentration (Cmax) of plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Carotid IMT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hb concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Post-test depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-test systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Antibody responses to IIV4-ID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of participants with at least one grade 2 or 3 systemic reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Receiving 4 or more Healthy Steps-related services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Being highly satisfied with care provided
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Receiving timely well-child visits and vaccinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal resuscitation program performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant spontaneous arousability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically important bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vomiting (WHO Grad 2)
Endpoint domain: Adverse events/effects
Primary endpoint: nausea (WHO Grad 2)
Endpoint domain: Adverse events/effects
Primary endpoint: alopecia
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary NGAL rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Health assessment questionnaire score ≤0.5 at week 12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvements in joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ability to recognize dysfunctional thinking patterns
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ability to view a situation from multiple perspectives
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: concentrations of ENO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: laryngeal exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Positive and Negative Syndrome Scale (PANSS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Central activation of the quadriceps femoris muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes